Risk factor
Strong & resilient to price shocks
Profitability factor
Very favourable analyst view
About
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, reasonably
Target Price
The average target price of UPR.IR is 5.1 and suggests 48% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell